Determinants of clinical severity in children with sickle cell disease and confirmed asthma

Gabriel Bafunyembaka1,2, Mathieu Nacher3, Ariel Makembi4

  • 1Department of Pediatrics, Centre Hospitalier de l'Ouest Guyanais (CHOG), Franck Joly Hospital, Saint-Laurent-du-Maroni, French Guiana, France.

Plos One
|April 28, 2026
PubMed

Insights

In children with sickle cell disease and asthma, over a third experience severe clinical outcomes. This study found no independent predictors of severity, highlighting the need for better risk stratification.

Area of Science:

  • Pediatric Hematology
  • Pulmonology
  • Infectious Diseases

Background:

  • Asthma is a common comorbidity in pediatric sickle cell disease (SCD).
  • SCD with asthma increases the risk of acute complications like vaso-occlusive crises and acute chest syndrome.
  • Factors influencing clinical severity in this co-occurrence are poorly understood, especially in tropical regions.

Purpose of the Study:

  • To identify factors associated with clinical severity in children with SCD and confirmed asthma.
  • To characterize the determinants of severe disease in this vulnerable pediatric population.

Main Methods:

  • An observational study was conducted in French Guiana.
  • Included were children with SCD and confirmed asthma.
  • Clinical severity was defined by ≥2 hospitalizations for vaso-occlusive crises and/or acute chest syndrome in 12 months.
  • Univariate and multivariate logistic regression analyses identified associated factors.

Main Results:

  • 138 children with SCD and asthma were analyzed; 73.9% had severe disease.
  • No independent predictors of clinical severity were found in multivariate analysis.
  • Trends suggested increased severity risk in rural areas and a protective effect of Strongyloides stercoralis infection.
  • Allergic sensitization was not associated with severity.

Conclusions:

  • Over one-third of children with SCD and asthma experience severe clinical disease.
  • No independent predictors of severity were identified in this cohort.
  • Findings suggest a need for stratified approaches to manage sickle cell-associated asthma and prevent complications.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
43
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K